AATS: 2009 Program: Sunday, May 10

AATS: American Association for Thoracic Surgery.

2009 Program and Abstracts

Preliminary Program Outline

« 2009 Program Index

SUNDAY, MAY 10, 2009 \| AATS/STS Postgraduate Symposia
8:00 am - 5:00 pm		AATS/STS ADULT CARDIAC SURGURY SYMPOSIUM Ballroom 20 A-C, Hynes Convention Center Chairmen: Michael A. Acker, MD Joseph E. Bavaria, MD University of Pennsylvania
Session I		Thoracic Aorta
8:00am – 8:20 am		TEVAR: Indications, Current Trends and Results G. Chad Hughes, MD
8:20am – 8:40 am		TEVAR in Setting of Aortic Dissection: Type A and B Alberto Pochettino, MD University of Pennsylvania
8:40am – 9:00 am		Hybrid Arch Wilson Y. Szeto, MD University of Pennsylvania
9:00 am - 9:15 am		Discussion
Session II		Aortic Root/Aortic Valve
9:15 am - 9:35 am		Aortic Valve Repair/Retention with Aortic Root Disease G. Michael Deeb, MD University of Michigan
9:35 am - 9:55 am		Aortic Valve Repair without Root Pathology Tricuspid/Bicuspid Gebrine El Khoury St-Luc Hospital
9:55 am - 10:15 am		BREAK
10:15 am - 10:35 am		Transcatheter Aortic Valve Replacement: Transfemoral Joseph E. Bavaria, MD University of Pennsylvania
10:35 am - 10:55 am		Transcatheter Aortic Valve Replacement: Transapical Todd M. Dewey, MD Medical City Dallas Hospital
10:55 am - 11:10 am		Discussion
Session III		Mitral Valve Repair
11:10 am - 11:30 am		3-D Echo: Clinical Breakthrough or Pretty Pictures? Joseph S. Savino, MD University of Pennsylvania
11:30 am-11:50 am		Degenerative Disease: Complex Repair Made Simple David H. Adams, MD Mount Sinai Medical Center
11:50 am - 12:05 pm		Discussion
12:05 pm - 1:05 pm		LUNCH
Session IV		Surgical Decision Making: When Are Two Valve Procedures Better Than One?/ Atrial Fibrillation
1:05 pm - 1:25 pm		The Surgical Treatment of Atrial Fibrillation: Are We Ready for Prime Time? Niv Ad, MD Fairfax Hospital
1:25 pm - 1:45 pm		Aortic Stenosis/ Mitral Regurgitation:When to Repair the Mitral Valve? Thomas G. Gleason, MD University of Pittsburgh
1:45 pm - 2:05 pm		Mitral Stenosis/Mitral Regurgitation and Tricuspid Regurgitation: When to Repair the Tricuspid Valve? Richard J. Shemin, MD University of California, Los Angeles
2:05 pm - 2:20 pm		Discussion
Session V		Heart Failure
2:20 pm - 2:40 pm		Should Functional Mitral Regurgitation in Heart Failure Patients be Repaired? Patrick M. McCarthy, MD Northwestern University
2:40 pm - 3:00 pm		Small VADs: Solution for Heart Failure Michael A. Acker, MD University of Pennsylvania
3:00 pm - 3:20 pm		Indications for Surgical Revascularization in Heart Failure Patients Y. Joseph Woo, MD University of Pennsylvania
3:20 pm - 3:35 pm		Discussion
3:35 pm - 3:55 pm		BREAK
Session VI		Coronary Artery Bypass
3:55 pm - 4:15 pm		Drug Eluding Stents: Has the Pendulum Started to Swing Back? David P. Taggart, MD University of Oxford
4:15 pm - 4:35 pm		Debate– Optimal Coronary Revascularization: Off Pump (Puskas) vs. On Pump (Sabik) vs. Hybrid (Byrne) John D. Puskas, MD Emory University Joseph F. Sabik, MD Cleveland Clinic John G. Byrne, MD Vanderbilt Heart Institute
4:35 pm - 4:50 pm		Discussion
5:00 pm		Welcome Reception Exhibit Hall

SUNDAY, MAY 10, 2009
8:00 am - 5:00 pm		GENERAL THORACIC SURGERY SYMPOSIUM Room 302-306, Hynes Convention Center Chairman: David H. Harpole, Jr., MD Duke University
8:00 am - 8:10 am		Introduction and Course Overview David H. Harpole, Jr., MD Duke University
Session I		Non-small Cell Lung Cancer
8:10 am - 8:30 am		New Lung Cancer Staging System Joe B. Putnam, MD Vanderbilt University
8:30 am - 9:00 am		Chemotherapy 101 Ramaswamy Govindan, MD Washington University
9:00 am - 9:30 am		Tyrosine Kinase Inhibitors Pasi A. Janne, MD, PhD Dana-Farber Cancer Institute
9:30 am - 10:00 am		Anti-angiogenesis and other Molecular Targets Thomas J. Lynch, MD Massachusetts General Hospital
10:00 am - 10:15 am		Discussion
10:15 am - 10:45 am		BREAK
10:45 am - 11:15 am		Radiotherapy 101 Jeffrey Bogart, MD State University of New York Upstate Medical University
11:15 am - 11:45 am		Current Early Stage Lung Cancer Trials Eric Valleries, MD Swedish Cancer Institute
11:45 am - 12:00 pm		Discussion
12:00 pm - 1:00 pm		LUNCH
Session II		Controversies in Lung Cancer
1:00 pm - 1:30 pm		Mediastinscopy or EBUS/EUS Bryan F. Meyers, MD, MPH Washington University
1:30 pm - 2:00 pm		Who is Medically Inoperable? Robert J. Cerfolio, MD University of Alabama
2:00 pm - 2:30 pm		Ablative Therapies for Nodules Jo-Anne O. Shepard, MD Massachusetts General Hospital
2:30 pm - 3:00 pm		Upfront or Outback Chemotherapy Ramaswamy Govindan, MD Washington University
3:00 pm - 3:30 pm		BREAK
Session III		Updates of General Thoracic Surgery
3:30 pm - 4:00 pm		STS Database Risk Adjustment Cameron D. Wright, MD Massachusetts General Hospital
4:00 pm - 4:20 pm		Pulmonary Metastasectomy Thomas A. D’Amico, MD Duke University
4:20 pm - 4:40 pm		Interventions for Emphysema Malcolm M. DeCamp, MD Beth Israel Deaconess Medical Center
4:40 pm - 5:00 pm		Discussion
5:00 pm		WELCOME RECEPTION – Exhibit Hall
8:00 am - 5:00 pm		Congenital Heart Disease Symposium Room 312, Hynes Convention Center Chairman:J. William Gaynor, MD Children’s Hospital of Philadelphia
		Welcome and Introduction: J. William Gaynor, MD Children’s Hospital of Philadelphia
Session I		Pro/Con Debate: NIRS is “Standard of Care” for Post-operative Management
8:00 am - 8:15 am		Pro: James S. Tweddell, MD Medical College of Wisconsin
8:15 am - 8:30 am		Con: Jennifer C. Hirsch, MD University of Michigan
8:30 am - 9:00 am		Discussion
Session II		Surgical Techniques “How I Do It”
9:00 am - 9:20 am		Aortic Valvuloplasty for Aortic Regurgitation Richard A. Jonas, MD Children’s National Medical Center
9:20 am - 9:30 am		Discussion
Session III		Pro/Con Debate: Use of a Fenestration Should be Routine During the Fontan Procedure
9:30 am - 9:45 am		Pro: Scott M. Bradley, MD Medical University of South Carolina
9:45 am - 10:00 am		Con: Frank L. Hanley, MD Stanford University
10:00 am - 10:30 am		Discussion
10:30 am - 10:50 am		BREAK
Session IV		Clinical Research in Pediatric Cardiac Surgery: How Can We Do Better?
10:50 am - 11:05 am		Uses and Limitations of Academic and Registry Databases William G. Williams, MD The Hospital for Sick Children
11:05 am - 11:20 am		Randomized Treament Trials: Lessons Learned from the BCAS and Other Studies Jane W. Newburger, MD, MPH Children’s Hospital Boston
11:20 am - 11:35 am		Multi-institutional Studies: Lessons Learned from the CHSS Studies Christopher A. Caldarone, MD The Hospital for Sick Children
11:35 am - 11:50 am		Multi-institutional Studies: Lessons Learned from the SVR Trial Richard G. Ohye, MD University of Michigan
11:50 am - 12:00 pm		Discussion
12:00 pm - 1:00 pm		LUNCH
	Session V–Variability in Outcomes
1:00 pm - 1:20 pm		Perioperative Genomics: Why do “Similar” Patients have Different Outcomes? Mark F. Newman, MD Duke University
1:20 pm - 1:40 pm		Does Protocol Driven Post-operative Management Improve Outcomes? Peter C. Laussen, MD Children’s Hospital Boston
1:40 pm - 2:00 pm		Difficulties Comparing Outcomes Between Institutions Karl F. Welke, MD Oregon Health and Science University
2:00 pm - 2:20 pm		How Do We Translate Clinical Research to Clinical Practice? Gil Wernovsky, MD Children’s Hospital of Philadelphia
2:20 pm – 2:30 pm		Discussion
Session VI		Surgical Techniques: “How I Do It”
2:30 pm - 2:50 pm		Living-Donor Lobar Lung Transplantation Vaughn A. Starnes, MD University of Southern California
2:50 pm - 3:00 pm		Discussion
3:00 pm - 3:20 pm		BREAK
Session VII		The Fontan/Kreutzer Procedure at 40
3:20 pm - 3:30 pm		Surgical Repair of Tricuspid Atresia Francis M. Fontan, MD
3:30 pm - 3:40 pm		An Operation for Correction of Tricuspid Atresia Guillermo O. Kreutzer, MD Ricardo Gutierrez Children’s Hospital
3:40 pm - 4:00 pm		Evolution of the Fontan/Kreutzer Procedure Marc R. de Leval, MD International Congenital Cardiac Centre
4:00 pm - 4:20 pm		Current Status of Survivors of the Fontan/Kreutzer Procedure Jack Rychik, MD Children’s Hospital of Philadelphia
4:20 pm - 4:40 pm		The Fontan/Kreutzer Procedure: Future Directions Edward L. Bove, MD University of Michigan
4:40 pm - 5:00 pm		Discussion
5:00 pm		WELCOME RECEPTION – Exhibit Hall

SUNDAY AFTERNOON, MAY 10, 2009
3:00 pm - 5:00 pm		C. WALTON LILLEHEI RESIDENT FORUM SESSION Room 311, Hynes Convention Center (7 minutes presentation, 8 minutes discussion) Moderators: Gus J. Vlahakes, MD Ara A. Vaporciyan, MD L1. In Vivo Structure and Function of Engineered Pulmonary Valves Danielle Gottlieb,1 Kunal Tandon,¹ Sitaram Emani,¹ Elena Aikawa,² David W. Brown,¹ Andrew J. Powell,¹ Arthur Nedder,¹ Michael S. Sacks,³ John E. Mayer¹ 1. Children’s Hospital Boston and Harvard Medical School, Boston, MA, USA 2. Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA 3. University of Pittsburgh, Pittsburgh, PA, USA L2. The Graft Imaging to Improve Patency (GRIIP) Trial Results Steve Singh, Nimesh Desai, Genta Chikazawa, Hiroshi Tsuneyoshi, Visal Pen, Jessica Vincent, Jennifer Ku, Fuad Moussa, Gideon Cohen, George Christakis, Stephen E. Fremes Sunnybrook Health Sciences Centre, Toronto, ON, Canada L3. Tissue Engineered Pro-Angiogenic Fibroblast Matrix Improves Myocardial Perfusion and Function and Limits Ventricular Remodeling Following Infarction J. Raymond Fitzpatrick, John R. Frederick, Ryan C. McCormick, David A. Harris, Ah-Young Kim, Max J. Smith, Carine M. Laporte, Jeffrey R. Muenzer, Alex J. Gambogi, Y. Joseph Woo Division of Cardiovascular Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, USA L4. Atorvastatin at Reperfusion Reduces Myocardial Infarct Size in Mice by Activating eNOS of Bone Marrow-derived Cells Zequan Yang,¹ Gorav Ailawadi,¹ Joel Linden,² Brent A. French,³ Irving L. Kron¹ 1. Surgery, University of Virginia Health System, Charlottesville, VA, USA 2. Medicine, University of Virginia Health System, Charlottesville, VA, USA 3. Biomedical Engineering, University of Virginia Health System, Charlottesville, VA, USA L5. Quantitative Assessment of Technical Proficiency of Residents in Cardiac Surgery Hiroo Takayama, Yoshifumi Naka, Mehmet C. Oz, Allan S. Stewart, Mathew R. Williams, Craig R. Smith, Micheal Argenziano Columbia University, New York, NY, USA L6. Divergent Impact of Osteopontin Isoforms on Lung Cancer Angiogenesis Justin D. Blasberg, Jessica S. Donington, Chandra M. Goparaju, Harvey I. Pass New York University Medical Center, New York, NY, USA L7. Temporary Acute Mechanical Circulatory Support for Acute Circulatory Collapse: Experience with 266 Patients Kristopher B. Deatrick, Amit K. Mathur, Ann Schumar, Robert H. Bartlett, Francis D. Pagani, Jonathan W. Haft Cardiac Surgery, The University of Michigan, Ann Arbor, MI, USA L8. Age is an Independent Risk Factor for Aspiration Following Thoracotomy for Pulmonary Resection William B. Keeling,¹ Jonathan M. Hernandez,² Vicki Lewis,³ Melissa Czapla,³ Weiwei Zhu,³ Joseph Garrett,² Eric Sommers² 1. Emory University, Atlanta, GA, USA 2. University Of South Florida, Tampa, FL, USA 3. H. Lee Moffitt Cancer Center, Tampa, FL, USA
5:00 pm		WELCOME RECEPTION – Exhibit Hall

« 2009 Program Index

Policies | Find a Surgeon | About | Contact

We Model Excellence

Copyright © American Association for Thoracic Surgery. All rights reserved.
Read the Privacy Policy.
IMPORTANT REMINDER: The preceding information is intended only to provide
general guidance and not as a definitive basis for diagnosis or treatment in any particular case.
It is very important that you consult a doctor about any specific medical problem or question.